(Q38468647)

3 September 2017

title

Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain (English)

1 reference

3 September 2017

0 references

A Berger

1

1 reference

3 September 2017

E Dukes

series ordinal

2

1 reference

3 September 2017

S Mercadante

series ordinal

3

1 reference

3 September 2017

G Oster

series ordinal

4

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

European Journal of Cancer Care

3 September 2017

published in

1 reference

3 September 2017

volume

15

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

138-145

1 reference

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

Clinical characteristics and economic costs of patients with painful neuropathic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

21 January 2018

Cancer pain management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

Assessment and treatment of neuropathic cancer pain following WHO guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

Neuropathic pain in cancer and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

Barriers to effective cancer pain management: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

Cancer pain: pathophysiology and syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

Strategies for the treatment of cancer pain in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

Management of cancer pain in Denmark: a nationwide questionnaire survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

Treatment of cancer pain in Norway. A questionnaire study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00624.X

10.1111/J.1365-2354.2005.00624.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference